Newsbenzinga
Invivyd Outlines Accelerated Approval Submission Path with FDA for COVID-19 Antibody
· Published
Article summary
Invivyd reported Phase 3 LIBERTY trial data for VYD2311, showing strong safety and enhanced COVID-19 antibody levels.
An excerpt from the original article.
Comments —
Loading comments…